SU683624A3 - Method of the preparation of thieno /3,2-c/ pyridine derivatives or their salts - Google Patents

Method of the preparation of thieno /3,2-c/ pyridine derivatives or their salts

Info

Publication number
SU683624A3
SU683624A3 SU772451699A SU2451699A SU683624A3 SU 683624 A3 SU683624 A3 SU 683624A3 SU 772451699 A SU772451699 A SU 772451699A SU 2451699 A SU2451699 A SU 2451699A SU 683624 A3 SU683624 A3 SU 683624A3
Authority
SU
USSR - Soviet Union
Prior art keywords
thieno
salts
preparation
pyridine derivatives
alkyl
Prior art date
Application number
SU772451699A
Other languages
Russian (ru)
Inventor
Трокслер Франц
Вискотт Эрик
Original Assignee
Сандос Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сандос Аг (Фирма) filed Critical Сандос Аг (Фирма)
Application granted granted Critical
Publication of SU683624A3 publication Critical patent/SU683624A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

Цель изобретени  - способ получени  новых соединений, обладающих ценными свойствам.и. Согласно данному .изобретению описываетс  способ получени  производных тиено (3, 2-е пиридина общей формулы I или их солей, заключающийс  в том, что соединение общей формулы OCH CHCHilfHRj где RI, R2 и Нз имеют указанное значение, подвергают взаимодействию с аитидридом карболовой кислоты общей формулы ( R4CO)2O, где 4 :имеет указанное значение, с последующим выделением целевого грродукта в свободном виде или в виде соли. Пример 1. 4-(3-т/9ег-Бутила1Мино-2 онаноило«сипропокои )-тиено 3, 2-е пиридин-З-карбоЕитрил . К 2,7 г леларгоновой кислоты и 1,3 г 4-(3-трег-бутил-амино - 2 - окои-пропокси)тиено {3, 2-е ,пир,иди -3-карбонит.рила в 12 мл хлороформа прибавл ют ло капл м при 0° С il,5 г ангидрида пеларго овой кислоты .в 3 тл хлороформ,а и выдерживают в течение 15 чпри комнатной температуре. После добавлени  50 мл i2 н. .раствора едкого натра трижды экстрагируют хлористым .метиленом, сушат MgS04, отфильтровывают и концентрируют, получают щелевой продукт; т. пл. гидромалеината 105-107° С (тетрагидрофуран). Пример 2. 1-г 5ег-Бутиламино-3-{3циантиено |з, 2-е лиридил-4-окси-(2-пропил )-гидросукцинат. 1 г 4-(3 - трет - бутиламино-2-океипрО покси)-тивно 3, 2-е лиридин-З-карбонитрилпи; ромалеината раствор ют -в 15 мл лед ной уксусной кислоты и смещивают при комнатной темлературе с 0,48 г  нтарного ангидрида. Спуст  15 ч смешивают с 50 л(л эфира, получают гидромалеинат; т. пл. 134- 137° С. Аналогично примеру I получают следующие соединени  формулы I, представленные в таблице.The purpose of the invention is a method of obtaining new compounds with valuable properties. According to the present invention, a method for the preparation of thieno derivatives (3, 2-nd pyridine of general formula I or their salts, comprising the compound of the general formula OCH CHCHilfHRj, of the formula (R4CO) 2O, where 4: has the indicated meaning, followed by separation of the desired cusp product in free form or in the form of salt. e pyridine-3-carboitrile. To 2.7 g of largonic acid and 1.3 g of 4- (3-tri-butyls but - 2 - okoi-propoxy) thieno {3, 2-nd, a feast, go -3-carbonitolil in 12 ml of chloroform was added dropwise at 0 ° C il, 5 g of anhydride of pelarboic acid. in 3 t chloroform, a, and incubated for 15 hours at room temperature.After adding 50 ml of i2N. sodium hydroxide solution is extracted three times with methylene chloride, dried MgSO4, filtered and concentrated, get a slit product; T. hydromalo maleinate 105-107 ° C (tetrahydrofuran). Example 2. 1-g 5g-Butylamino-3- {3 cyanthieno | h, 2nd liridyl-4-hydroxy- (2-propyl) -hydrosuccinate. 1 g of 4- (3-tert-butylamino-2-oxyproxypoxy) -tivno 3, 2nd eridine-3-carbonitrile; Romaleinate is dissolved in 15 ml of glacial acetic acid and displaced at room temperature from 0.48 g of succinic anhydride. After 15 hours, mixed with 50 liters (1 of ether, the hydromaleicate is obtained; mp 134-137 ° C. Analogously to Example I, the following compounds of formula I are presented in the table.

При применении смеси хлороформ - гексаметилфосфортриамид вместо хлороформа в качестве растворител . When using a mixture of chloroform - hexamethylphosphoric triamide instead of chloroform as a solvent.

Приведена температура плавлени  гидромалоната. ( , Формула -изобретени  1. Способ получени  производных тиено 3,2-е пиридина общей формулы Ri-t I где RI - водород, алкил Ci-C4, хлор, бром, наход щиес  в положении 2, 3 или 7, или фтор, иди циано (1 :1) группа, наход щиес  в лоложении 2 или 3; водород, алкил С -;-С4, хлор или бром, наход щиес  в положении 2, 3 или 7, или фтор в положении 2 иди ; алкил Сз-С/; алкил Ci-Ci7, фенил, незамещенный или замещенный нитрогруппой , .одним или двум  алкильными радикалами Ci-€4, атомом фтора, хлора или брома одной, двум  или трем  The melting point of hydromalonate is given. (Formula of the invention: 1. A method for producing thieno derivatives of 3,2-e pyridine of the general formula: Ri-t I where RI is hydrogen, alkyl Ci-C4, chlorine, bromine, which are in position 2, 3 or 7, or fluorine, go cyano (1: 1) group in position 2 or 3; hydrogen, alkyl C -; - C4, chlorine or bromine, which are in position 2, 3 or 7, or fluorine in position 2 or go; alkyl Cz- C /; alkyl Ci-Ci7, phenyl, unsubstituted or substituted by a nitro group, with one or two alkyl radicals Ci-4, with a fluorine, chlorine or bromine atom of one, two or three

алиоксигруппам  Ci-€4, илиC-€ 4 alioxy groups, or

группа -{СН2)п СООН, где пgroup - {CH2) n COOH, where n

означает число 2 или 3,means the number 2 or 3,

или их солей, отдичающийс   тем, что. соединение общейor their salts, being distinguished by the fact that. compound common

формулыformulas

бК tftaiiCHCHiNffPs.bq tftaiiCHCHiNffPs.

inin

ЬB

гg

где RI, Ra, Нз имеют указанные значе н ,where RI, Ra, Hz have the indicated values,

подвергают взаимодействию с ангидридои карболовой кислоты общей формулыare reacted with carbolic anhydride of general formula

(К4СО)20(K4SO) 20

где R4 имеет указанные значени , с последующим выделением целевого продукта в свободном виде или в виде соли.where R4 is as defined, followed by isolation of the desired product in free form or as a salt.

Источник ;инфopiмaциiи, прин тый во внимание при экспертизе:Source; information, taken into account during the examination:

1. Патент ГДР № 107031, класс 12 р 2, 1974.1. Patent of the GDR No. 107031, class 12 p 2, 1974.

SU772451699A 1976-02-09 1977-02-09 Method of the preparation of thieno /3,2-c/ pyridine derivatives or their salts SU683624A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH153076A CH619956A5 (en) 1976-02-09 1976-02-09 Process for the preparation of novel thieno[3,2-c]pyridine derivatives

Publications (1)

Publication Number Publication Date
SU683624A3 true SU683624A3 (en) 1979-08-30

Family

ID=4212597

Family Applications (1)

Application Number Title Priority Date Filing Date
SU772451699A SU683624A3 (en) 1976-02-09 1977-02-09 Method of the preparation of thieno /3,2-c/ pyridine derivatives or their salts

Country Status (21)

Country Link
JP (1) JPS5297995A (en)
AT (1) AT363088B (en)
AU (1) AU512534B2 (en)
BE (1) BE851180A (en)
CA (1) CA1078844A (en)
CH (2) CH619956A5 (en)
DE (1) DE2703888A1 (en)
DK (1) DK42077A (en)
ES (1) ES455701A1 (en)
FI (1) FI770320A (en)
FR (1) FR2340320A1 (en)
GB (1) GB1570328A (en)
IE (1) IE44438B1 (en)
IL (1) IL51396A (en)
NL (1) NL7701179A (en)
NZ (1) NZ183267A (en)
PH (1) PH13659A (en)
PT (1) PT66166B (en)
SE (1) SE7700962L (en)
SU (1) SU683624A3 (en)
ZA (1) ZA77742B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53153946U (en) * 1977-05-10 1978-12-04
FR2452490A1 (en) * 1979-03-30 1980-10-24 Sanofi Sa 2-Hydroxy-3-aminopropoxy thieno-pyridine derivs. - useful as antiinflammatories, beta blockers and antiarrhythmics for human and veterinary medicine
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds

Also Published As

Publication number Publication date
AT363088B (en) 1981-07-10
SE7700962L (en) 1977-08-10
AU512534B2 (en) 1980-10-16
CA1078844A (en) 1980-06-03
IL51396A (en) 1980-02-29
DE2703888A1 (en) 1977-08-11
IE44438B1 (en) 1981-12-02
PT66166A (en) 1977-03-01
AU2213677A (en) 1978-08-17
NL7701179A (en) 1977-08-11
IL51396A0 (en) 1977-04-29
JPS5297995A (en) 1977-08-17
FR2340320A1 (en) 1977-09-02
ATA80977A (en) 1980-12-15
CH619956A5 (en) 1980-10-31
PH13659A (en) 1980-08-21
NZ183267A (en) 1979-04-26
FR2340320B1 (en) 1980-03-14
ES455701A1 (en) 1978-04-16
BE851180A (en) 1977-08-08
IE44438L (en) 1977-08-09
DK42077A (en) 1977-08-10
GB1570328A (en) 1980-06-25
PT66166B (en) 1978-10-13
CH622796A5 (en) 1981-04-30
ZA77742B (en) 1978-09-27
FI770320A (en) 1977-08-10

Similar Documents

Publication Publication Date Title
US4216167A (en) 1,3 Diaminopropane derivatives
US4661607A (en) Furoxanthone derivatives useful as diuretics
DD219769A5 (en) PROCESS FOR THE PREPARATION OF 1,3-DIOXAN-5-YL-ALKANSANIC DERIVATIVES
DE68910550T2 (en) Sulfonamide compounds.
CA1093068A (en) Cephalosporin antibiotics
US4658055A (en) Method for manufacture of 7-(2,5-dioxocyclopentyl)heptanoic acid derivative
BRPI0110184B1 (en) pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
SU683624A3 (en) Method of the preparation of thieno /3,2-c/ pyridine derivatives or their salts
SU648087A3 (en) Method of obtaining sulfone
SU498912A3 (en) The method of obtaining triazolothiazole esters of phosphorus acids
US3933826A (en) Protoberberine derivatives
US4439436A (en) 1,3-Dioxolo(4,5-G)quinoline compounds
CA2085347C (en) Novel cyclic aminophenylacetic acid derivative, production therof, and immune response modulator containing the same as active ingredient
US4012387A (en) Benzo-[g]pyrido[2,1-b]quinazolinones
SU718011A3 (en) Method of producing phenylthieno-(2,3-c) piperidine derivatives or salts thereof
NO130329B (en)
DE69205886T2 (en) Benzopyran derivatives and process for their preparation.
DE2922231C2 (en)
US4355166A (en) Quinuclidinic ester and derivatives of phenoxycarboxylic acids
US4142048A (en) Production of tris-(2-hydroxyaryl) esters of cyanuric acid
SU1731059A3 (en) Method for synthesis of fused pyrazol derivatives or theirs pharmaceutically acceptable salts
SU701531A3 (en) Method of preparing oxime derivatives or their salts
US3872109A (en) Substituted 2-pyrones
IE47051B1 (en) Pyranoquinolinones
US3714218A (en) 3-benzoyl-3-thiocyanatopropionic acid, alkyl esters and derivatives thereof